Pyrimidine derivatives
US9758538B2 · kind B2 · utility
0Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2016 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Jul 13, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)or pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1-R11, m, n, and p are defined herein. The novel pyrimidine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.